UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

autophagy machinery is required to initiate hepatitis C virus replication

Proceedings of the National Academy of Sciences - PNAS, 2009-08, Vol.106 (33), p.14046-14051

2009

Volltextzugriff (PDF)

Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication

EMBO reports, 2016-07, Vol.17 (7), p.1013-1028

2016

Volltextzugriff (PDF)

Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection

Proceedings of the National Academy of Sciences - PNAS, 2010-04, Vol.107 (16), p.7431-7436

2010

Volltextzugriff (PDF)

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

Journal of Virology, 2008-03, Vol.82 (5), p.2120-2129

2008

Volltextzugriff (PDF)

Unbiased Probing of the Entire Hepatitis C Virus Life Cycle Identifies Clinical Compounds That Target Multiple Aspects of the Infection

Proceedings of the National Academy of Sciences - PNAS, 2010-01, Vol.107 (1), p.291-296

2010

Volltextzugriff (PDF)

Robust Hepatitis C Virus Infection in vitro

Proceedings of the National Academy of Sciences - PNAS, 2005-06, Vol.102 (26), p.9294-9299

2005

Volltextzugriff (PDF)

Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture

Journal of Virology, 2010-11, Vol.84 (21), p.10999-11009

2010

Volltextzugriff (PDF)

Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles

Journal of Virology, 2006-11, Vol.80 (22), p.11074-11081

2006

Volltextzugriff (PDF)

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Nature medicine, 2008-01, Vol.14 (1), p.25-27

2008

Volltextzugriff (PDF)

Sigma-1 Receptor Regulates Early Steps of Viral RNA Replication at the Onset of Hepatitis C Virus Infection

Journal of Virology, 2013-06, Vol.87 (11), p.6377-6390

2013

Volltextzugriff (PDF)

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

Frontiers in immunology, 2021-11, Vol.12, p.748103-748103

2021

Volltextzugriff (PDF)

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

Journal of virology, 2017-05, Vol.91 (10)

2017

Volltextzugriff (PDF)

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

Pharmaceuticals (Basel, Switzerland), 2021-04, Vol.14 (4), p.332

2021

Volltextzugriff (PDF)

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

Journal of Virology, 2006-11, Vol.80 (22), p.11082-11093

2006

Volltextzugriff (PDF)

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function

International journal of molecular sciences, 2022-03, Vol.23 (7), p.3448

2022

Volltextzugriff (PDF)

SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral

Pharmaceuticals (Basel, Switzerland), 2021-10, Vol.14 (10), p.1048

2021

Volltextzugriff (PDF)

Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron

Frontiers in immunology, 2022-04, Vol.13, p.863831-863831

2022

Volltextzugriff (PDF)

Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools

PLoS pathogens, 2022-01, Vol.18 (1), p.e1010210-e1010210

2022

Volltextzugriff (PDF)

Clathrin mediates infectious hepatitis C virus particle egress

Journal of virology, 2015-04, Vol.89 (8), p.4180-4190

2015

Volltextzugriff (PDF)

Imaging of Virus-Infected Cells with Soft X-ray Tomography

Viruses, 2021-10, Vol.13 (11), p.2109

2021

Volltextzugriff (PDF)

Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation

PLoS pathogens, 2018-09, Vol.14 (9), p.e1007284-e1007284

2018

Volltextzugriff (PDF)

virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro

Proceedings of the National Academy of Sciences - PNAS, 2008-02, Vol.105 (8), p.3088-3093

2008

Volltextzugriff (PDF)

SARS-CoV-2 and HCV infection and antiviral treatment monitored by multimodal imaging

BIO web of conferences, 2024, Vol.129, p.16002

2024

Volltextzugriff (PDF)

Elimination of HCV replication machinery early after antiviral treatment with DAA monitored by multimodal microscopy

BIO web of conferences, 2024, Vol.129, p.18008

2024

Volltextzugriff (PDF)

Cellular stress responses in hepatitis C virus infection: Mastering a two-edged sword

Virus research, 2015-11, Vol.209, p.100-117

2015

Volltextzugriff (PDF)

1 – 25 von 71

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(59)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(71)

Sprache

Englisch
(66)
Spanisch
(5)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

autophagy machinery is required to initiate hepatitis C virus replication

Long noncoding RNA EGOT negatively affects the antiviral response and favors HCV replication

Plasmacytoid dendritic cells sense hepatitis C virus-infected cells, produce interferon, and inhibit infection

Cellular Determinants of Hepatitis C Virus Assembly, Maturation, Degradation, and Secretion

Unbiased Probing of the Entire Hepatitis C Virus Life Cycle Identifies Clinical Compounds That Target Multiple Aspects of the Infection

Robust Hepatitis C Virus Infection in vitro

Ultrastructural and Biophysical Characterization of Hepatitis C Virus Particles Produced in Cell Culture

Differential Biophysical Properties of Infectious Intracellular and Secreted Hepatitis C Virus Particles

Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge

Sigma-1 Receptor Regulates Early Steps of Viral RNA Replication at the Onset of Hepatitis C Virus Infection

The Bacterial Mucosal Immunotherapy MV130 Protects Against SARS-CoV-2 Infection and Improves COVID-19 Vaccines Immunogenicity

Internal Disequilibria and Phenotypic Diversification during Replication of Hepatitis C Virus in a Noncoevolving Cellular Environment

Host-Directed FDA-Approved Drugs with Antiviral Activity against SARS-CoV-2 Identified by Hierarchical In Silico/In Vitro Screening Methods

Persistent Hepatitis C Virus Infection In Vitro: Coevolution of Virus and Host

Effect of Clinically Used Microtubule Targeting Drugs on Viral Infection and Transport Function

SARS-CoV-2 Fears Green: The Chlorophyll Catabolite Pheophorbide A Is a Potent Antiviral

Nanobodies Protecting From Lethal SARS-CoV-2 Infection Target Receptor Binding Epitopes Preserved in Virus Variants Other Than Omicron

Guanosine inhibits hepatitis C virus replication and increases indel frequencies, associated with altered intracellular nucleotide pools

Clathrin mediates infectious hepatitis C virus particle egress

Imaging of Virus-Infected Cells with Soft X-ray Tomography

Host phosphatidic acid phosphatase lipin1 is rate limiting for functional hepatitis C virus replicase complex formation

virocidal amphipathic α-helical peptide that inhibits hepatitis C virus infection in vitro

SARS-CoV-2 and HCV infection and antiviral treatment monitored by multimodal imaging

Elimination of HCV replication machinery early after antiviral treatment with DAA monitored by multimodal microscopy

Cellular stress responses in hepatitis C virus infection: Mastering a two-edged sword

Suchergebnisse filtern